Livongo

What Livongo does

Livongo by Teladoc Health is a chronic condition management platform that delivers personalized care programs for diabetes, hypertension, weight management, and diabetes prevention. Its integrated offering combines connected health-monitoring hardware (cellular-enabled blood glucose meters, blood pressure monitors, and scales), a mobile application, real-time data analytics, certified health coaching with Spanish-language support, 24/7 monitoring with immediate outreach for dangerous health events, and physician and mental health specialist access. The platform is built on clinical standards of care from the American Diabetes Association, American Heart Association, and CDC, and includes an add-on GLP-1 prescribing module for weight management members.

The company operates a B2B2C distribution model: programs are provided at no cost to eligible members but funded by employers, health plans, or healthcare providers who contract on per-member-per-month or per-eligible-life subscription terms. Livongo sells to enterprise benefit decision-makers and cross-sells through Teladoc Health's integrated virtual care platform, which serves over 92 million members across 175 countries following the 2020 acquisition. Since 2020, Livongo has operated as a wholly-owned subsidiary brand of Teladoc Health (NYSE: TDOC), with its chronic condition programs increasingly bundled with Teladoc's primary care and mental health services.

Livongo was founded in 2014, raised approximately $230 million in venture funding from General Catalyst, Kleiner Perkins, Kinnevik, Silver Lake, Merck Global Health Innovation Fund, Humana, and Sapphire Ventures among others, and reached a reported $1.87 billion market capitalization as a public company before being acquired by Teladoc Health for $18.5 billion. The company reports it has helped more than 730,000 patients, with documented outcomes including a 48% reduction in diabetes incidence over three years, 15mmHg average systolic blood pressure reduction, and 46% of weight management patients losing 5% or more of starting weight.

Name

Livongo

Legal name

Livongo Health, Inc.

Website

https://hello.livongo.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Livongo by Teladoc Health provides an integrated chronic condition management platform combining connected health devices, certified coaching, and 24/7 monitoring for diabetes, hypertension, weight management, and diabetes prevention, delivered through employer and health plan benefit programs as a B2B2C subscription service to over 730,000 members.

Ownership category

akta.pro rank

Product category

Digital Health Chronic Condition Management

NAICS

Home Health Care Services (62161)

SIC

Services-Health Services (8000), Services-Prepackaged Software (7372), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

akta.pro secondary industries

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD), Chronic Care & Remote Patient Monitoring (RPM) Platforms (HLALABAF)

Keywords

• Chronic condition management
• Digital health platform
• Remote patient monitoring
• Connected health devices
• Virtual care coaching

Headquarters

HQ city

Mountain View

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Employer-Sponsored Benefit Program: Livongo provides its chronic condition management programs at no cost to eligible members. The program is funded by employers, health plans, or healthcare providers who pay for the program on behalf of their employees/members. This B2B2C model generates revenue through per-member-per-month (PMPM) fees or per-eligible-life fees from enterprise clients.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Livongo provides a chronic condition management platform that combines connected health-monitoring devices (blood glucose meters, blood pressure monitors, and scales), a mobile app with real-time analytics, and dedicated certified health coaching to help members manage diabetes, hypertension, weight, and prediabetes. Programs are funded by employers and health plans on a per-member subscription basis and made available to eligible members at no cost as part of their benefits package.

Product overview

Livongo by Teladoc Health is a chronic condition management platform offering an integrated suite of programs for diabetes management, diabetes prevention, hypertension management, and weight management. The platform provides connected health-monitoring devices (blood glucose meters, blood pressure monitors, connected scales), certified health coaches, and physician support. Members can enroll in one or more programs and receive personalized health plans, 24/7 monitoring, and unlimited coaching support. The platform also offers GLP-1 prescribing as an add-on service for eligible members enrolled in condition management programs. Programs are available at no cost to members through employer or health plan benefits.

Differentiator

Problem solved

Functional benefit

Brands

• Livongo Condition Management: Chronic care management programs for diabetes, hypertension, weight management, and diabetes prevention featuring connected devices, health coaching, and personalized plans.

Products and services

• Diabetes Management A chronic condition management program providing connected blood glucose meters with unlimited strips, real-time insights, expert coaching, and 24/7 monitoring to help members with type 1 or type 2 diabetes track blood sugar levels and develop healthier lifestyle habits.
• Diabetes Prevention Program A prediabetes management program featuring medically certified content, activity tracking, and ongoing coaching to help members prevent the onset of type 2 diabetes.
• Hypertension Management A blood pressure management program offering a connected blood pressure monitor, daily tracking through a mobile app, and personalized tips on nutrition, stress, and exercise to help reduce blood pressure.
• Weight Management A weight loss and management program providing tips and techniques for improving nutrition, exercise, and weight loss, with support from health coaches and a connected scale.
• Condition Management Program An integrated chronic condition management platform offering connected health-monitoring devices, certified health coaches, and support from physicians and mental health specialists for conditions including diabetes, hypertension, and weight management.
• GLP-1 Prescribing GLP-1 medication prescribing available to members enrolled in condition management programs when clinically appropriate, offered in addition to lifestyle modification guidance with support from nutritionists, expert coaching, and licensed professionals.

Quantifiable outcome

• 48% reduced incidence of diabetes over a three-year period
• +4 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Teladoc HealthcoreStrategic or Co-development PartnerTeladoc Health acquired Livongo for $18.5 billion in 2020, creating an integrated virtual care platform combining Livongo's chronic condition management (diabetes, hypertension, weight) with Teladoc's primary care and mental health services. Livongo operates as a subsidiary brand under Teladoc Health, which now serves over 92 million members across 175 countries.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Omada Health: Omada Health offers a digital chronic care platform spanning diabetes prevention, diabetes management, hypertension, and behavioral health, sold primarily through employer and health plan benefit programs. It is the most direct head-to-head competitor to Livongo's core B2B2C chronic condition management offering.
• Virta Health: Virta Health provides a clinically oriented digital diabetes reversal and type 2 diabetes management program delivered via telehealth, remote monitoring, and coaching, with a strong employer/payer distribution model. It competes with Livongo on diabetes outcomes, coaching quality, and enterprise contracts.
• Noom: Noom operates a behavior change and weight management platform with a growing chronic condition and prevention offering sold through employers and health plans. It competes with Livongo's Weight Management and Diabetes Prevention programs, particularly in self-insured employer benefits.
• Vida Health: Vida Health is a virtual chronic care provider covering diabetes, hypertension, weight management, and mental health, delivered via coaching and connected devices and sold to employers and payers. Its multi-condition virtual care model directly overlaps with Livongo's integrated platform.
• DarioHealth: DarioHealth provides a digital therapeutics platform for diabetes, hypertension, musculoskeletal, and behavioral health, including connected devices and coaching, primarily through employers, health plans, and pharmacy benefit managers. It competes with Livongo in chronic condition management, particularly in self-funded employer markets.
• Lark Health: Lark Health offers an AI-driven digital health platform focused on diabetes prevention, diabetes management, hypertension, and behavioral health, sold through health plans and employers. Its AI coaching-led model targets the same employer and payer customers as Livongo.
• One Drop: One Drop is a digital health company offering a connected blood glucose monitoring platform combined with AI-driven coaching and behavioral programs for diabetes, hypertension, and weight management. It competes directly with Livongo on device-based diabetes engagement.
• mySugr (Roche): mySugr, part of Roche, provides a diabetes management app with connected device integrations, coaching, and bolus calculator functionality used by people with diabetes globally. It overlaps with Livongo's diabetes management product, particularly in consumer and payer-distributed use cases.

Broad incumbents

• Amwell: Amwell is a large-scale virtual care platform serving health systems, insurers, and employers across urgent care, behavioral health, and chronic condition management. As a broader incumbent, Amwell competes with Livongo/Teladoc at the enterprise virtual care platform layer rather than as a focused chronic care specialist.

Emerging players

• Verily Life Sciences: Verily (Alphabet) develops digital health and chronic disease programs including diabetes (via Onduo) and population health analytics, often through employer and payer pilots. It is an emerging player overlapping with Livongo's chronic care roadmap, with potential for significant scale given Alphabet backing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/livongo
• YouTubeyoutube.com/user/livongo
• Facebookfacebook.com/livongo
• LinkedInlinkedin.com/company/livongo
• Instagraminstagram.com/livongo_health

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds6 records

Investors19 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Livongo